Drug Firms to Drop ARV Prices – Clinton Foundation
In a massive breakthrough for poor countries struggling to meet the demand for antiretrovirals (ARVs), the Clinton Foundation has signed an agreement with two key US drug companies to make HIV-AIDS and tuberculosis (TB) treatment more affordable for developing countries.
Former US president, Bill Clinton, says that Maylan and its extension Matrix had agreed to make available a second line therapy for HIV-infected people. The second line package, inclusive of ARVs Azanavir, Ritonavir, Tenofovir, and Lamivudine (3TC), will be sold at less than R4 000 a year.
Developing countries in Africa, Asia, Eastern Europe, Latin America, the Middle East and the Caribbean that are part of the Clinton Foundation’s Procurement Consortium will benefit from the price reduction.
To read the article titled, “Drug firms to drop Aids pills prices,” click here.
Former US president, Bill Clinton, says that Maylan and its extension Matrix had agreed to make available a second line therapy for HIV-infected people. The second line package, inclusive of ARVs Azanavir, Ritonavir, Tenofovir, and Lamivudine (3TC), will be sold at less than R4 000 a year.
Developing countries in Africa, Asia, Eastern Europe, Latin America, the Middle East and the Caribbean that are part of the Clinton Foundation’s Procurement Consortium will benefit from the price reduction.
To read the article titled, “Drug firms to drop Aids pills prices,” click here.
Source:
<br /> Sowetan
Article link:
Share this:
Printer-friendly versionAdd Comments
Vacancies
Events
-
Monday, February 13, 2012
-
Wednesday, February 15, 2012
-
Wednesday, February 15, 2012
Opportunities
-
10/02/2012
-
10/02/2012
-
13/02/2012
-
14/02/2012
-
15/02/2012
This is an example to be
By ThomWestley